These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 24196787

  • 21. Low miR-133a expression is a predictor of outcome in patients with esophageal squamous cell cancer.
    Gao SH, Liu J, Zhang HJ, Zhao N, Zhang J.
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3788-3792. PubMed ID: 27735040
    [Abstract] [Full Text] [Related]

  • 22. XIAP 3'-untranslated region as a ceRNA promotes FSCN1 function in inducing the progression of breast cancer by binding endogenous miR-29a-5p.
    Wu Q, Yan H, Tao SQ, Wang XN, Mou L, Chen P, Cheng XW, Wu WY, Wu ZS.
    Oncotarget; 2017 Mar 07; 8(10):16784-16800. PubMed ID: 28186968
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA‑145 inhibits the malignant phenotypes of gastric carcinoma cells via downregulation of fascin 1 expression.
    Xue M, Zhao L, Yang F, Li Z, Li G.
    Mol Med Rep; 2016 Jan 07; 13(1):1033-9. PubMed ID: 26647829
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The clinicopathological significance of miR-133a in colorectal cancer.
    Wan TM, Lam CS, Ng L, Chow AK, Wong SK, Li HS, Man JH, Lo OS, Foo D, Cheung A, Yau T, Poon JT, Poon RT, Law WL, Pang RW.
    Dis Markers; 2014 Jan 07; 2014():919283. PubMed ID: 25104873
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
    Gao X, Xie Z, Wang Z, Cheng K, Liang K, Song Z.
    Yonsei Med J; 2017 Nov 07; 58(6):1101-1110. PubMed ID: 29047233
    [Abstract] [Full Text] [Related]

  • 29. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
    Li YQ, Lu JH, Bao XM, Wang XF, Wu JH, Hong WQ.
    J Exp Clin Cancer Res; 2015 Oct 26; 34():130. PubMed ID: 26503504
    [Abstract] [Full Text] [Related]

  • 30. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1.
    Fuse M, Nohata N, Kojima S, Sakamoto S, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, Naya Y, Ichikawa T, Seki N.
    Int J Oncol; 2011 Apr 26; 38(4):1093-101. PubMed ID: 21258769
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
    Du YY, Zhao LM, Chen L, Sang MX, Li J, Ma M, Liu JF.
    J Gastroenterol Hepatol; 2016 Feb 26; 31(2):384-93. PubMed ID: 26414725
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression.
    He Z, Li W, Zheng T, Liu D, Zhao S.
    J Exp Clin Cancer Res; 2020 Jul 22; 39(1):140. PubMed ID: 32698859
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. MiR-133a suppresses the migration and invasion of esophageal cancer cells by targeting the EMT regulator SOX4.
    Li S, Qin X, Li Y, Zhang X, Niu R, Zhang H, Cui A, An W, Wang X.
    Am J Transl Res; 2015 Jul 22; 7(8):1390-403. PubMed ID: 26396670
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.